Global Blood Therapeutics, Inc. (GBT) financial statements (2022 and earlier)

Company profile

Business Address 181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:735495302275315147149
Cash and cash equivalents68549530227519892149
Short-term investments    11655 
Other undisclosed cash, cash equivalents, and short-term investments50      
Receivables29183    
Inventory, net of allowances, customer advances and progress billings58401    
Inventory58401    
Prepaid expense 1396421
Other current assets   2611
Other undisclosed current assets(20)67312202   
Total current assets:802632628486324150151
Noncurrent Assets
Operating lease, right-of-use asset485153
Property, plant and equipment353827151722
Long-term investments and receivables50   1550 
Long-term investments50   1550 
Restricted cash and investments2222100
Other noncurrent assets21100  
Other undisclosed noncurrent assets  85114   
Total noncurrent assets:1379216813232532
TOTAL ASSETS:939724796618357202153
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities82747033261510
Accounts payable1519116743
Accrued liabilities393141171054
Employee-related liabilities28241810952
Other liabilities6521011
Total current liabilities:88797134261611
Noncurrent Liabilities
Long-term debt and lease obligation320228146    
Long-term debt, excluding current maturities24614974    
Operating lease, liability747972
Liabilities, other than long-term debt110111212
Other liabilities110111212
Other undisclosed noncurrent liabilities334      
Total noncurrent liabilities:655229146111212
Total liabilities:74330821745381612
Stockholders' equity
Stockholders' equity attributable to parent196416579573319186141
Common stock0000000
Additional paid in capital1,4861,4021,3171,045617367239
Accumulated other comprehensive income (loss)001(0)(0)(0) 
Accumulated deficit(1,290)(986)(739)(472)(298)(181)(98)
Total stockholders' equity:196416579573319186141
TOTAL LIABILITIES AND EQUITY:939724796618357202153

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1951242   0
Revenue, net  0
Cost of revenue
(Cost of Goods and Services Sold)
(3)(2)     
Gross profit:1911222   0
Operating expenses(479)(366)(292)(183)(119)(83)(46)
Other undisclosed operating income (loss) 18   (0)
Operating loss:(288)(243)(281)(183)(119)(83)(46)
Nonoperating income (expense)(15)(4)    0
Investment income, nonoperating      0
Other nonoperating expense(15)(4)     
Interest and debt expense(104)(49)(31)    
Loss from continuing operations before equity method investments, income taxes:(407)(296)(313)(183)(119)(83)(46)
Other undisclosed income from continuing operations before income taxes1044946921 
Loss from continuing operations before income taxes:(303)(248)(267)(174)(117)(82)(46)
Income tax expense(0)      
Net loss:(303)(248)(267)(174)(117)(82)(46)
Other undisclosed net loss attributable to parent  (0)(0)   
Net loss attributable to parent:(303)(248)(267)(174)(117)(82)(46)
Other undisclosed net loss available to common stockholders, basic      (4)
Net loss available to common stockholders, diluted:(303)(248)(267)(174)(117)(82)(51)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(303)(248)(267)(174)(117)(82)(46)
Other comprehensive loss(0)      
Comprehensive loss:(303)(248)(267)(174)(117)(82)(46)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (0)10(0)(0) 
Comprehensive loss, net of tax, attributable to parent:(303)(248)(266)(174)(117)(83)(46)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: